Healthcare Contract Research Organizations (CRO) Services Market Report 2031 by Segments, Geography, Dynamics, Recent Developments, and Strategic Insights

Healthcare Contract Research Organizations (CRO) Services Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapeutic Indication (Neurological Disorders, Oncology, Respiratory Diseases, Infectious Diseases, Cardiovascular Diseases, and Others); Service Type (Laboratory Services, Early Phase Development, Consulting Services, and Clinical Research Services); End User (Medical Device Companies, Pharmaceutical and Biopharmaceutical Companies, and Others), and Geography

  • Report Code : TIPRE00010465
  • Category : Life Sciences
  • Status : Data Released
  • No. of Pages : 150
Buy Now

The healthcare contract research organizations (CRO) services market size projected to reach US$ 102.86 billion by 2031 from US$ 57.31 billion in 2023. The market is expected to register a CAGR of 7.6% in 2023–2031. The increasing clinical studies globally will likely remain a key healthcare contract research organization's (CRO) services market trend.  

Healthcare Contract Research Organizations (CRO) Services Market Analysis

Factors such as increasing demand for novel drugs, increasing chronic diseases prevalence, and growth in funding programs to conduct clinical trials are responsible for propelling the number of clinical trials worldwide. The management of clinical trials requires extended research facilities, dedicated resources, and adequate financial requirements. These prerequisites of clinical trials generate a productive environment to prefer a contract research organization to execute clinical studies. The above factors will boost the market growth over the forecast period.

Healthcare Contract Research Organizations (CRO) Services Market Overview

Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms for chronic diseases. Asthma is the most common chronic disease among children across the globe and the WHO estimated that around 263 million people are living with asthma across the globe. Thus, the growing prevalence of chronic disorders is likely to lead to the development of new pharmaceuticals, which will further accelerate the growth of the healthcare contract research organizations (CRO) services market.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Healthcare Contract Research Organizations (CRO) Services Market: Strategic Insights

healthcare-cro-services-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Healthcare Contract Research Organizations (CRO) Services Market Drivers and Opportunities

Increasing Outsourcing Activities to Favor Market

Many companies are establishing strategic partnerships with contract research organizations. For instance, in January 2020, Aragen Bioscience, Inc, a subsidiary of GVK BIO, one of the significant players in pre-clinical CRO, entered into a strategic collaboration with Serum Institute of India Pvt. Ltd. to accelerate the R&D of multiple stable cell lines under Serum’s HIV program. Moreover, In 2022, Labcorp spin off its CRO segment, named Fortrea, which stands to “forward trials with ease” will work as an independent publicly traded CRO, and provide drug and medical device services, including clinical trial management and commercialization offerings.

Rising Biosimilars and Biologics Market – An Opportunity in Healthcare Contract Research Organizations (CRO) Services Market

The biotechnology industry expands scientists' toolboxes, and the combination of basic research, translational studies, and clinical trials will continue to develop, investigate, and test additional compounds, techniques, and therapeutic pathways. Biotechnology is a strategic sector for China. The Made in China 2025 initiative aims to produce high-tech products, including innovative medicines. The plan introduced targets for Chinese pharmaceutical companies to spur biotechnology innovation and increase exports. Furthermore, these Asian countries use genomics, proteomics, and biomarker advancements for diagnostic and therapeutic applications. Therefore, the ongoing evolution of the biotechnology industry in developing regions will create opportunities for the biologics and biosimilars market in the coming years.

Healthcare Contract Research Organizations (CRO) Services Market Report Segmentation Analysis

Key segments contributing to the derivation of the Healthcare Contract Research Organizations (CRO) Services market analysis are service type, therapeutic indication, and end user.

  • Based on service type, the healthcare contract research organizations (CRO) services market is divided into early phase development, laboratory services, consulting services, and clinical research services. The clinical research services segment held a larger market share in 2023.
  •  Based on therapeutic indication, the market is segmented into oncology, infectious diseases, respiratory diseases, cardiovascular diseases, neurological disorders, and others. The others segment held a larger market share in 2023.
  • In terms of end user, the market is segmented into medical device companies, pharmaceutical and biopharmaceutical companies, and others. The pharmaceutical and biopharmaceutical companies segment dominated the market in 2023.

Healthcare Contract Research Organizations (CRO) Services Market Share Analysis by Geography

The geographic scope of the Healthcare Contract Research Organizations (CRO) Services market report is mainly divided into five regions: North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The healthcare contract research organizations (CRO) services market in North America is significant. In North America, the growth of the healthcare contract research organizations (CRO) services market is primarily driven by high regulatory standards followed by the pharmaceutical industry, an increasing number of clinical trials, and the rapid growth of the biosimilars and biologics market. Marge pharmaceutical companies are expected to grow R&D spending at 4% per annum, I.e., US$234 billion by 2025. Likewise, biotechnology R&D spending is forecast to grow up to 8% per annum. The above factors is expected to affect the healthcare contract research organizations (CRO) positively services market growth.

Healthcare Contract Research Organizations (CRO) Services Market Regional Insights

The regional trends and factors influencing the Healthcare Contract Research Organizations (CRO) Services Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Healthcare Contract Research Organizations (CRO) Services Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

healthcare-cro-services-market-global-geography
  • Get the Regional Specific Data for Healthcare Contract Research Organizations (CRO) Services Market

Healthcare Contract Research Organizations (CRO) Services Market Report Scope

Report Attribute Details
Market size in 2023 US$ 57.31 Billion
Market Size by 2031 US$ 102.86 Billion
Global CAGR (2023 - 2031) 7.6%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Service Type
  • Early Phase Development
  • Laboratory Services
  • Consulting Services
  • Clinical Research Services
By Therapeutic Indication
  • Oncology
  • Infectious Diseases
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Neurological Disorders
By End User
  • Medical Device Companies
  • Pharmaceutical and Biopharmaceutical Companies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Charles River Laboratories Inc.
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Parexel International Corporation
  • Icon Plc.
  • Pra Health Sciences
  • Syneos Health
  • Medpace
  • Wuxi Apptec
  • PPD Inc

  • Healthcare Contract Research Organizations (CRO) Services Market Players Density: Understanding Its Impact on Business Dynamics

    The Healthcare Contract Research Organizations (CRO) Services Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Healthcare Contract Research Organizations (CRO) Services Market are:

    1. Charles River Laboratories Inc.
    2. IQVIA Inc.
    3. Laboratory Corporation of America Holdings
    4. Parexel International Corporation
    5. Icon Plc.
    6. Pra Health Sciences

    Disclaimer: The companies listed above are not ranked in any particular order.


    healthcare-cro-services-market-speedometer

    • Get the Healthcare Contract Research Organizations (CRO) Services Market top key players overview
     

    Healthcare Contract Research Organizations (CRO) Services Market News and Recent Developments

    The Healthcare Contract Research Organizations (CRO) Services market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:

    • In June 2021, LINK Medical, a full-service contract research organization (CRO) for the pharmaceutical and medical device industries, signed a contract to join forces with Insife, an expert consulting and technology service provider for safety and pharmacovigilance organizations. (Source: LINK Medical, Press Release)
    • In April 2020, Accelerated Enrollment Solutions (AES), a business of PPD, Inc., launched a new program to help biopharmaceutical companies maintain business continuity during the global COVID-19 pandemic by transferring clinical trial patients to AES’ dedicated research sites from other research facilities that the coronavirus crisis has impacted. (Source: PPD, Inc, Newsletter)

    Healthcare Contract Research Organizations (CRO) Services Market Report Coverage and Deliverables

    The “Healthcare Contract Research Organizations (CRO) Services Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

    • Healthcare Contract Research Organizations (CRO) Services market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Healthcare Contract Research Organizations (CRO) Services market trends
    • Detailed PEST and SWOT analysis
    • Healthcare Contract Research Organizations (CRO) Services market covering key market trends, Global and regional framework, major players, regulations, and recent market developments
    • Healthcare Contract Research Organizations (CRO) Services industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    Service Type ; Therapeutic Indication ; End User ; and Geography

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    Trends and growth analysis reports related to Life Sciences : READ MORE..   


    Buy Now